Acceptable safety of bevacizumab therapy in patients with brain metastases due to non-small cell lung cancer

被引：25
|
作者：
Akerley, W. L.
Langer, C. J.
Oh, Y.
Strickland, D. K.
Royer, S. Joo
Xia, Q.
Mu, Y.
Huang, J.
Socinski, M. A.
机构：
[1] Univ Utah, Salt Lake City, UT USA
[2] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.8043
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8043
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety of bevacizumab therapy in subjects with brain metastases due to non-small cell lung cancer (NSCLC)
    Akerley, Wallace
    Hainsworth, John
    Oh, Yun
    Strickland, Dk
    Royer-Joo, Stephanie
    Zhou, Xian
    Xia, Qi
    Huang, Jane
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S467 - S467
  • [2] Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain Metastases
    Socinski, Mark A.
    Langer, Corey J.
    Huang, Jane E.
    Kolb, Margaret M.
    Compton, Peter
    Wang, Lisa
    Akerley, Wallace
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) : 5255 - 5261
  • [3] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Mustafa S. Ascha
    Jacqueline Fang Wang
    Priya Kumthekar
    Andrew E. Sloan
    Carol Kruchko
    Jill S. Barnholtz-Sloan
    [J]. Scientific Reports, 9
  • [4] Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
    Ascha, Mustafa S.
    Wang, Jacqueline Fang
    Kumthekar, Priya
    Sloan, Andrew E.
    Kruchko, Carol
    Barnholtz-Sloan, Jill S.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    Kevin C. De Braganca
    Yelena Y. Janjigian
    Christopher G. Azzoli
    Mark G. Kris
    Maria C. Pietanza
    Craig P. Nolan
    Antonio M. Omuro
    Andrei I. Holodny
    Andrew B. Lassman
    [J]. Journal of Neuro-Oncology, 2010, 100 : 443 - 447
  • [6] Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases.
    Ichiki, Masao
    Yoshida, Tsukasa
    Nakamura, Masayuki
    Kumano, Tomomi
    Hoshino, Tomoaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer
    De Braganca, Kevin C.
    Janjigian, Yelena Y.
    Azzoli, Christopher G.
    Kris, Mark G.
    Pietanza, Maria C.
    Nolan, Craig P.
    Omuro, Antonio M.
    Holodny, Andrei I.
    Lassman, Andrew B.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (03) : 443 - 447
  • [8] Brain metastases in advanced non-small cell lung cancer post bevacizumab
    Huang Yujuan
    Yang Jinji
    Wang Zhen
    Huang Yisheng
    Wu Yilong
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S684 - S684
  • [9] THE ADMINISTRATION OF BEVACIZUMAB FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES
    Fukunaga, Kentaro
    Kawashima, Satoru
    Yoshihashi, Saiko
    Seto, Ruriko
    Kanda, Rie
    Higami, Yuichi
    Goto, Kenichi
    Ryujin, Yasushi
    Nakagawa, Hiroaki
    Van Tho, Nguyen
    Yamaguchi, Masafumi
    Oguma, Tetuya
    Nagao, Taishi
    Ogawa, Emiko
    Nakano, Yasutaka
    [J]. RESPIROLOGY, 2013, 18 : 87 - 87
  • [10] Effect of erlotinib plus bevacizumab on brain metastases in patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Kanayama, Masatoshi
    Taira, Akihiro
    Nabe, Yusuke
    Shinohara, Shinji
    Kuwata, Taiji
    Takenaka, Masaru
    Oka, Soichi
    Hirai, Ayako
    Kuroda, Koji
    Imanishi, Naoko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (20)
12345